550 related articles for article (PubMed ID: 37857941)
1. Epigenetic regulation of breast cancer metastasis.
Thakur C; Qiu Y; Pawar A; Chen F
Cancer Metastasis Rev; 2024 Jun; 43(2):597-619. PubMed ID: 37857941
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.
Park M; Kim D; Ko S; Kim A; Mo K; Yoon H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743249
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Cell Death Dis; 2017 Feb; 8(2):e2578. PubMed ID: 28151481
[TBL] [Abstract][Full Text] [Related]
4. miRNAs: Critical mediators of breast cancer metastatic programming.
Nair MG; Somashekaraiah VM; Ramamurthy V; Prabhu JS; Sridhar TS
Exp Cell Res; 2021 Apr; 401(1):112518. PubMed ID: 33607102
[TBL] [Abstract][Full Text] [Related]
5. Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.
So JY; Skrypek N; Yang HH; Merchant AS; Nelson GW; Chen WD; Ishii H; Chen JM; Hu G; Achyut BR; Yoon EC; Han L; Huang C; Cam MC; Zhao K; Lee MP; Yang L
Cancer Res; 2020 Jun; 80(12):2612-2627. PubMed ID: 32265226
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives.
Medeiros B; Allan AL
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071959
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
[TBL] [Abstract][Full Text] [Related]
9. Obesity-associated epigenetic alterations and the obesity-breast cancer axis.
Lagarde CB; Kavalakatt J; Benz MC; Hawes ML; Arbogast CA; Cullen NM; McConnell EC; Rinderle C; Hebert KL; Khosla M; Belgodere JA; Hoang VT; Collins-Burow BM; Bunnell BA; Burow ME; Alahari SK
Oncogene; 2024 Mar; 43(11):763-775. PubMed ID: 38310162
[TBL] [Abstract][Full Text] [Related]
10. New insights into the mechanisms of organ-specific breast cancer metastasis.
Lorusso G; Rüegg C
Semin Cancer Biol; 2012 Jun; 22(3):226-33. PubMed ID: 22504658
[TBL] [Abstract][Full Text] [Related]
11. The importance of microRNAs in the stroma-breast cancer cell interplay.
Susman S; Tomuleasa C; Fekete Z; Pilato B; Irimie A; Berindan-Neagoe I
Cancer Biomark; 2014; 14(2-3):137-44. PubMed ID: 24878814
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cells: Multiple capacities in tumor metastasis.
Geng SQ; Alexandrou AT; Li JJ
Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic and metabolic regulation of breast cancer stem cells.
Liu HX; Li XL; Dong CF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
[TBL] [Abstract][Full Text] [Related]
14. Human breast cancer metastases to the brain display GABAergic properties in the neural niche.
Neman J; Termini J; Wilczynski S; Vaidehi N; Choy C; Kowolik CM; Li H; Hambrecht AC; Roberts E; Jandial R
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):984-9. PubMed ID: 24395782
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?
Fazilaty H; Gardaneh M; Bahrami T; Salmaninejad A; Behnam B
Tumour Biol; 2013 Aug; 34(4):2019-30. PubMed ID: 23686802
[TBL] [Abstract][Full Text] [Related]
16. Molecular principles of metastasis: a hallmark of cancer revisited.
Fares J; Fares MY; Khachfe HH; Salhab HA; Fares Y
Signal Transduct Target Ther; 2020 Mar; 5(1):28. PubMed ID: 32296047
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer.
Toska E
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189097. PubMed ID: 38518961
[TBL] [Abstract][Full Text] [Related]
18. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Metastatic Potential in a 3D Tissue Scaffold toward a Comprehensive in Vitro Model for Breast Cancer Metastasis.
Balachander GM; Balaji SA; Rangarajan A; Chatterjee K
ACS Appl Mater Interfaces; 2015 Dec; 7(50):27810-22. PubMed ID: 26599258
[TBL] [Abstract][Full Text] [Related]
20. Histone demethylase RBP2 is critical for breast cancer progression and metastasis.
Cao J; Liu Z; Cheung WK; Zhao M; Chen SY; Chan SW; Booth CJ; Nguyen DX; Yan Q
Cell Rep; 2014 Mar; 6(5):868-77. PubMed ID: 24582965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
